Eating Disorder: Clinical Trials

2 trials for Eating Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Eating Disorder: new trials by email Literature Review of Eating Disorder trials Research Report on Eating Disorder

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Monoamine Contributions to Neurocircuitry in Eating Disorders
[11C]raclopride, [11C]DASB, amphetamine - Eating Disorder
Phase 4CompletedUniversity of California, San Diego882011-05-012020-04-27
Naltrexone Treatment for Alcoholic Women
naltrexone, Placebo - Alcoholism, Eating Disorder
Phase 4CompletedYale University1601995-10-012014-05-07

Narrower conditions

Feeding and Eating Disorders (2)  ·  Alcoholism (1)

Broader conditions

Mental Disorders (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)  ·  Alcohol-Related Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile (1)  ·  Amphetamine (1)  ·  Dextroamphetamine (1)  ·  Naltrexone (1)  ·  Raclopride (1)

Sponsors

University of California, San Diego (1)  ·  Yale University (1)

Countries

United States (2)

Top investigators

Stephanie S O'Malley, PhD (1)  ·  Ursula Bailer, MD (1)  ·  Walter Kaye, MD (1)

Results publications

PMID 17374042

NIH funding

R01AA010225 (1), R01MH092793 (1)